The consumption of Brassica vegetables provides beneficial effects through organic isothiocyanates (ITCs), products of the enzymatic hydrolysis of glucosinolate secondary metabolites. The ITC l-sulforaphane (l-SFN) is the principle agent in broccoli that demonstrates several modes of anticancer action. While the anticancer properties of ITCs like l-SFN have been extensively studied and l-SFN has been the subject of multiple human clinical trials, the scope of this work has largely been limited to those derivatives found in nature. Previous studies have demonstrated that structural changes in an ITC can lead to marked differences in a compound's potency to 1) inhibit the growth of cancer cells, and 2) alter cellular transcriptional profiles. This study describes the preparation of a library of non-natural aryl ITCs and the development of a bifurcated screening approach to evaluate the dose- and time-dependence on antiproliferative and chemopreventive properties against human MCF-7 breast cancer cells. Antiproliferative effects were evaluated using a commercial MTS cell viability assay. Chemopreventive properties were evaluated using an antioxidant response element (ARE)-promoted luciferase reporter assay. The results of this study have led to the identification of 1) several key structure-activity relationships and 2) lead ITCs for continued development.
The consumption of Brassica vegetables pn class="Chemical">rovides beneficial effects through organic isothiocyanates (ITCs), products of the enzymatic hydrolysis of glucosinolate secondary metabolites. The ITC l-sulforaphane (l-SFN) is the principle agent in broccoli that demonstrates several modes of anticancer action. While the anticancer properties of ITCs like l-SFN have been extensively studied and l-SFN has been the subject of multiple human clinical trials, the scope of this work has largely been limited to those derivatives found in nature. Previous studies have demonstrated that structural changes in an ITC can lead to marked differences in a compound's potency to 1) inhibit the growth of cancer cells, and 2) alter cellular transcriptional profiles. This study describes the preparation of a library of non-natural aryl ITCs and the development of a bifurcated screening approach to evaluate the dose- and time-dependence on antiproliferative and chemopreventive properties against humanMCF-7 breast cancer cells. Antiproliferative effects were evaluated using a commercial MTS cell viability assay. Chemopreventive properties were evaluated using an antioxidant response element (ARE)-promoted luciferase reporter assay. The results of this study have led to the identification of 1) several key structure-activity relationships and 2) lead ITCs for continued development.
Authors: Yanxia Liu; Jonathan T Kern; John R Walker; Jeffrey A Johnson; Peter G Schultz; Hendrik Luesch Journal: Proc Natl Acad Sci U S A Date: 2007-03-12 Impact factor: 11.205
Authors: Rong Hu; Vidya Hebbar; Bok-Ryang Kim; Chi Chen; Bozena Winnik; Brian Buckley; Patricia Soteropoulos; Peter Tolias; Ronald P Hart; A-N Tony Kong Journal: J Pharmacol Exp Ther Date: 2004-02-26 Impact factor: 4.030
Authors: Claire C Fanta; Kaitlyn J Tlusty; Sarah E Pauley; Amanda L Johnson; Genevieve A Benjamin; Taylor K Yseth; Michaela M Bunde; Paul T Pierce; Shirley Wang; Peter F Vitiello; Jared R Mays Journal: ChemMedChem Date: 2022-06-09 Impact factor: 3.540